- Description of the product: eye drops
- Decision: the product is a medical device approved for circulation in Poland
- VAT rate: 8%
- The product is a Class IIa medical device with natural ingredients found in tears
- The product’s certificate is valid until at least May 27, 2024
Source: sip.lex.pl
Note that this post was (partially) written with the help of AI. It is always useful to review the original source material, and where needed to obtain (local) advice from a specialist.
Latest Posts in "Poland"
- Poland’s Mandatory KSeF E-Invoicing: Key Dates, Requirements, and Compliance for Businesses
- Mandatory KSeF Implementation: Technical Setbacks and Process Challenges After VAT Law Amendment in Poland
- Over 35 Million Invoices Issued in KSeF Since Mandatory E-Invoicing Began in February 2026
- KSeF Causes Invoice Surge: From 10 to 170 Electricity Bills for Housing Cooperatives
- KSeF as a Shift Toward Preventive Tax Administration and Fewer Sanctions
